HALO logo
halo search icon
Legend Biotech Corp. Sponsored ADR
Legend Biotech Corp. Sponsored ADR
LEGN · NAS

Legend Biotech Corp. Sponsored ADR

US$28.12

Price Arrow1.18 (4.38%)
20/05/2026 04:00:01 PM
All-ConsensusConsensus CheapDefying GravityRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Legend Biotech Corp. Sponsored ADR Overview

LEGN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About LEGN

icon

Telephone

1.737.317.5050

icon

Address

2101 Cottontail Lane, Somerset, NJ 08873

Description

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

LEGN Price Chart

Key Stats

Market Cap

US$4.98B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 16.24 - 45.3

Trade Value (12mth)

US$12,763,098.00

1 week

-2.21%

1 month

6.82%

YTD

25.24%

1 year

-4.91%

All time high

77.32

Key Fundamentals

EPS 3 yr Growth

-42.40%

EBITDA Margin

-10.50%

Operating Cashflow

-$100m

Free Cash Flow Return

-8.10%

ROIC

-24.00%

Interest Coverage

-5.00

Quick Ratio

1.90

Other Data

Shares Outstanding (Fully Diluted)

185m

HALO Sector

Healthcare

Next Company Report Date

16-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

LEGN Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
14 April 26
11 March 26

LEGN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.94-0.97-1.61locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.94-0.97-1.61locklocklock
Growth
%locklocklocklock-4.967.1-66.7locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Legend Biotech Corp. Sponsored ADR (LEGN:NAS)?
Halo FAQ
The current share price of Legend Biotech Corp. Sponsored ADR (LEGN:NAS) is USD$28.12.
What is the 52-week high share price for Legend Biotech Corp. Sponsored ADR (LEGN:NAS)?
Halo FAQ
The 52-week high share price for Legend Biotech Corp. Sponsored ADR (LEGN:NAS) is USD$45.30.
What is the 52-week low share price for Legend Biotech Corp. Sponsored ADR (LEGN:NAS)?
Halo FAQ
The 52-week low share price for Legend Biotech Corp. Sponsored ADR (LEGN:NAS) is USD$16.24.
What is the dividend yield for Legend Biotech Corp. Sponsored ADR (LEGN:NAS)?
Halo FAQ
Legend Biotech Corp. Sponsored ADR (LEGN:NAS) does not pay a dividend.
What was Legend Biotech Corp. Sponsored ADR (LEGN:NAS) last dividend payment?
Halo FAQ
Legend Biotech Corp. Sponsored ADR (LEGN:NAS) does not pay a dividend.
What is the franking level for Legend Biotech Corp. Sponsored ADR (LEGN:NAS)?
Halo FAQ
Legend Biotech Corp. Sponsored ADR (LEGN:NAS) has a franking level of 0.00%.
In which sector is Legend Biotech Corp. Sponsored ADR (LEGN:NAS) classified?
Halo FAQ
Legend Biotech Corp. Sponsored ADR (LEGN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.